Showing results (81-90 of 494) with videos related to
Sort By:
Pageof 50
Expert Review of Anticancer Therapy|December 23, 2017
How to use neoadjuvant medical treatment to maximize surgery in melanomaTeresa Amaral, Ioanna Tampouri, Claus GarbeCancer Immunology, Immunotherapy : CII|October 28, 2020
Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitorsJohanna Winter, Max M Lenders, Maximilian Gassenmaier, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
VemurafenibClaus Garbe, Sail Abusaif, Thomas K EigentlerExpert Opinion on Biological Therapy|September 12, 2017
Immunotherapy in managing metastatic melanoma: which treatment when?Teresa Amaral, Francisco Meraz-Torres, Claus GarbeExpert Opinion on Pharmacotherapy|September 3, 2013
Protein kinase inhibitors in melanomaThomas K Eigentler, Friedegund Meier, Claus GarbeJournal of the American Academy of Dermatology|December 3, 2023
Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort studyNikolaus B Wagner, Sarah M Knierim, Felix Luttermann, et al.Melanoma Research|April 9, 2010
Cutaneous melanoma in the elderly: epidemiology, prognosis and treatmentKonstantinos G Lasithiotakis, Ioannis E Petrakis, Claus GarbeJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology GroupRoland Kaufmann, Konstanze Spieth, Ulrike Leiter, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 23, 2014
Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screeningNora Eisemann, Annika Waldmann, Claus Garbe, et al.Journal of Cutaneous Pathology|April 22, 2008
Distribution of muscarinic receptor subtype M3 in melanomas and their metastasesMatthias Oppitz, Christian Busch, Claus Garbe, et al.Pageof 50